1. Treating complex femoropopliteal lesions.
- Author
-
van der Vijver-Coppen RJ, 't Mannetje YW, Menting TP, Lardenoije JW, and Reijnen MP
- Subjects
- Coated Materials, Biocompatible, Drug-Eluting Stents, Femoral Artery physiopathology, Humans, Intermittent Claudication diagnosis, Intermittent Claudication physiopathology, Ischemia diagnosis, Ischemia physiopathology, Peripheral Arterial Disease diagnosis, Peripheral Arterial Disease physiopathology, Polytetrafluoroethylene chemistry, Popliteal Artery physiopathology, Treatment Outcome, Vascular Access Devices, Vascular Patency, Angioplasty, Balloon adverse effects, Angioplasty, Balloon instrumentation, Atherectomy adverse effects, Endarterectomy adverse effects, Femoral Artery surgery, Intermittent Claudication therapy, Ischemia therapy, Peripheral Arterial Disease therapy, Popliteal Artery surgery, Vascular Grafting adverse effects
- Abstract
Peripheral artery disease affects 202 million patients worldwide and may cause disabling intermittent claudication and critical limb ischemia. Next to life style changes, best medical treatment and supervised exercise therapy, it can be necessary to re-vascularize the limb. Treatment of femoropopliteal lesions poses a challenge and a surgical bypass remains recommended in the guidelines for longer and more complex lesions. Bypass surgery is associated with substantial morbidity and even mortality. Endovascular alternatives are quickly evolving from plain balloon angioplasty to drug-eluting stents, drug-coated balloons, polytetrafluoroethylene-covered stents and atherectomy. These developments might challenge the gold standard in the near future. This article focuses on which technique can be used for which femoropopliteal lesion, particularly complex lesions, and summarizes the most recent and important literature on this topic.
- Published
- 2018
- Full Text
- View/download PDF